Medication info
Dagli Tablets (Glimepiride)

Dagli Tablets (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Hwa-il Pharmaceutical Co., Ltd.
Appearance
Green rectangular tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 201308597 · Approved 2013.07.31 · Insurance code 684500850

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, little additional effect is seen with doses greater than 4 mg, although some patients achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previous medication. 4) Dose adjustment During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. Generally, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management while taking a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Hwa-il Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to help control blood glucose levels in patients with type 2 diabetes. Taking this medication alongside dietary control and exercise can make blood sugar management more effective. It can be used alone or, in some cases, in combination with other hypoglycemic agents or insulin. For example, if oral hypoglycemic agents are ineffective in controlling blood glucose, it may be administered with insulin, or in cases where control is difficult with sulfonylureas or metformin monotherapy, it may be given in combination with metformin. This helps to improve blood glucose control in various ways.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, little additional effect is seen with doses greater than 4 mg, although some patients achieved better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering agent to this medicine There is no precise dose equivalence between this medicine and other oral glucose-lowering agents. When switching from another oral glucose-lowering agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previous medication. 4) Dose adjustment During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. Generally, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur after initial successful management while taking a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or coma. Patients who are allergic to this medication or its components, or to sulfonylureas, should not be administered this medication. There is no experience with this medication in patients with severe liver or kidney dysfunction, and in such cases, switching to insulin therapy is recommended. Pregnant women, women who may become pregnant, and nursing mothers should also refrain from taking this medication. It is advisable to apply insulin therapy for patients with severe infections, especially before and after surgery or for those who have sustained major trauma. Patients with gastrointestinal disturbances such as diarrhea or vomiting should be cautious as impaired food absorption increases the risk of hypoglycemia. Additionally, since this medication contains lactose, it is not given to patients with genetic issues like lactose intolerance or galactose intolerance. During the first week of taking this medication, the risk of hypoglycemia is heightened, so careful monitoring of blood glucose levels is particularly important. Patients or situations at high risk for hypoglycemia include elderly individuals who may be less cooperative, those with poor nutritional status or irregular eating habits, excessive exercise or changes in food intake, and those who consume alcohol. Patients with impaired kidney or liver function may also react more sensitively to this medication, so adjustments may be necessary. Additionally, caution is needed for patients with thyroid, pituitary, or adrenal dysfunctions, the elderly, and those on other medications. In these cases, blood glucose should be checked frequently, and if hypoglycemia symptoms occur, the doctor or pharmacist should be informed, and dosage or administration methods should be adjusted as necessary. This medication contains the dye Yellow No. 5, so patients allergic to this ingredient should use it with caution. The most important side effect to be cautious of while taking this medication is hypoglycemia. When hypoglycemia occurs, various symptoms such as headache, severe hunger, nausea, fatigue, anxiety, reduced concentration, confusion, dizziness, drowsiness, and loss of consciousness can manifest. In severe cases, it may lead to seizures or coma, requiring immediate treatment. Additionally, during the initial period of medication, temporary blurring of vision may occur due to blood sugar changes, and gastrointestinal disturbances, liver function abnormalities, blood anomalies, and allergic reactions may rarely occur. In particular, if allergic symptoms such as hives or difficulty breathing appear, the physician should be notified immediately, and in severe cases, medication should be discontinued. When taking this medication, it is important to take it regularly and to adhere to dietary and exercise regimens. If hypoglycemia occurs, consuming sugar or sugary drinks can quickly alleviate symptoms, so it is advisable to always carry a source of sugar. During the course of taking this medication, regular testing of blood glucose and urine is recommended, and if the effect is insufficient, other treatment options may be considered. Also, caution should be exercised when driving or operating machinery due to potential decreased alertness from hypoglycemia or hyperglycemia. This medication can interact with other drugs, so it is essential to inform the doctor or pharmacist when starting or stopping other medications. Especially if taken with drugs metabolized by the liver or drugs that raise or lower blood glucose levels, this can affect blood sugar control. Medications like beta-blockers can mask the symptoms of hypoglycemia, requiring caution. Moreover, alcohol consumption can unpredictably change the effects of this medication. Pregnant or nursing women are advised against taking this medication as it may affect the fetus or newborn. If necessary, switching to insulin therapy or stopping breastfeeding is recommended. The safety and efficacy of this medication in children under 18 have not been established, so it is best not to use it in this population. Elderly patients may have reduced kidney function, so adjusting the dosage of this medication may be necessary. In the event of an overdose of this medication, hypoglycemia symptoms may occur, so immediate medical treatment is required. Initially, emesis may be induced and adsorbent medications administered, and if necessary, glucose can be administered intravenously to regulate blood sugar levels. Symptoms of hypoglycemia may recur even after treatment, so careful observation for 24 to 48 hours is necessary. This medication should be stored out of reach of children and kept sealed in its original container to ensure safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, reduced concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, partial paralysis, perceptual disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein issues, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is recommended to keep the medication at room temperature, avoiding extremes of heat or cold, ideally between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Green rectangular tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.